Industrial hemp has been used as a textile for thousands of years as a natural fiber. It can be processed into thousands of different finished goods and it is one of the only plants on earth that has little to no negative impact on the environment in the production and processing of the plant.
The hemp plant can be manufactured into many finished textiles: clothes, shoes, canvas, furniture, rope, curtains, bed sheets, pillows, towels, curtains, carpeting, blankets, backpacks, insulation and so much more. Hemp fiber is the longest, strongest natural fiber on earth. Products made from hemp fiber are stronger and last longer than current conventional materials.
Hemp is one of the most reliable and sustainable natural fibers on earth. Unlike cotton fiber, hemp requires a fraction of the water, fertilizer, herbicides or pesticides.
The market for industrial hemp fibers continues to expand year over year. With thousands of applications, the possibilities for investment in this emerging industry is significant.
The Industrial Hemp Fiber Market Report
The newly release Industrial Hemp Fiber Market Report from 360 Market Updates provides a detailed look of the market over the past 7 years and projections for the industry till 2023. The report contains information on leading trends in the market, demand & supply of raw materials, costs for processing and manufacturing, labor, growth rate, and many more topics regarding the hemp fiber industry.
The report can be purchased from 360 Market Updates via the link below.
Global Hemp Group (OTC: GBHPF) (CSE: GHG)
Shanxi Greenland Textile
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…